Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
María Espinosa Bosch
Observed names:
M Espinosa Bosch,
M. Espinosa Bosch,
MARÍA ESPINOSA BOSCH
Institution:
Hospital Regional Universitario de Málaga
Observed institutions:
Hospital Regional Universitario de Málaga,
Hospital Universitario Virgen del Rocío,
Universidad de Málaga
OpenAlex ID:
A5068423409
Recent Development in Optical Fiber Biosensors
2007
·
María Espinosa Bosch
, Antonio Jesús Ruiz Sánchez
, et al.
·
Sensors
·
288
PDF
Determination of paracetamol: Historical evolution
2006
·
M. Espinosa Bosch
, A.J. Ruiz Sánchez
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
256
Analytical methodologies for the determination of cisplatin
2008
·
M. Espinosa Bosch
, A.J. Ruiz Sánchez
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
101
Analytical methodologies for the determination of omeprazole: An overview
2007
·
M. Espinosa Bosch
, A.J. Ruiz Sánchez
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
66
Morphine and its metabolites: Analytical methodologies for its determination
2006
·
M. Espinosa Bosch
, A. Ruiz Sánchez
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
64
Recent developments in analytical determination of furosemide
2008
·
M. Espinosa Bosch
, A.J. Ruiz Sánchez
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
55
Analytical methodologies for the determination of sertraline
2008
·
M. Espinosa Bosch
, A.J. Ruiz Sánchez
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
34
Recent advances in analytical determination of thalidomide and its metabolites
2007
·
M. Espinosa Bosch
, A.J. Ruiz Sánchez
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
32
Ribavirin: Analytical determinations since the origin until today
2007
·
M. Espinosa Bosch
, A.J. Ruiz Sánchez
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
24
Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report.
2016
·
María Espinosa Bosch
, Rocío Asensi Diez
, et al.
·
PubMed
·
15
Review of analytical methodologies for the determination of 5-HT3 receptor antagonists
2017
·
M. Espinosa Bosch
, A.J. Ruiz Sánchez
, et al.
·
Microchemical Journal
·
10
Arsenic and antimony speciation analysis in the environment using hyphenated techniques to inductively coupled plasma mass spectrometry: a review
2009
·
M. Espinosa Bosch
, A.J. Ruiz Sanchez
, et al.
·
International Journal of Environment and Waste Management
·
9
Use of Experimental Design for Calibration and Validation of Ascorbic Acid and Citric Acid Mixtures
2008
·
F. Sánchez Rojas
, C. Bosch Ojeda
, et al.
·
Redalyc (Universidad Autónoma del Estado de México)
·
3
4CPS-200 Triple therapy for metastatic hormone-sensitive prostate cancer patients based on a pharmacological treatment algorithm
2024
·
R Tamayo Bermejo
, JC Del Río Valencia
, et al.
·
European Journal of Hospital Pharmacy
·
1
Compatibility and stability of drug mixtures: An overview
2022
·
María Espinosa Bosch
, Fuensanta Sánchez Rojas
, et al.
·
GSC Biological and Pharmaceutical Sciences
·
1
PDF
Binary mixtures of midazolam and furosemide stored in continuous infusion systems: Compatibility and stability
2016
·
María Espinosa Bosch
, F. Sánchez Rojas
, et al.
·
European journal of clinical pharmacy
·
1
Evaluation of large language models for clinical decision support in prostate cancer: a multidisciplinary Delphi study
2026
·
Ángel Borque-Fernando
, María José Ledo Cepero
, et al.
·
Journal of Comparative Effectiveness Research
6ER-009 Clinical benefit of new therapies indicated in diffuse large B-cell lymphoma
2026
·
R Díaz Perales
, B López Bautís
, et al.
·
European Journal of Hospital Pharmacy
4CPS-051 Cost saving impact of biosimilar trastuzumab for the treatment of HER-2 positive breast cancer in a hospital
2024
·
JD Paradas Palomo
, JC Del Rio Valencia
, et al.
·
European Journal of Hospital Pharmacy
PDF
4CPS-147 Osimertinib: a promising treatment for EGFR mutation-positive non-small-cell lung cancer
2024
·
R Tamayo Bermejo
, JC Del Río Valencia
, et al.
·
European Journal of Hospital Pharmacy
PDF
Efectividad Y Seguridad De Durvalumab En El Tratamiento Del Cáncer De Pulmón No Microcítico: Datos En La Práctica Clínica.
2024
·
RUBÉN DÍAZ PERALES
, ROCIO TAMAYO BERMEJO
, et al.
·
Sociedad Española de Farmacia Hospitalaria eBooks
5PSQ-137 Analysis of the dpyd gene mutations in cancer patients who are candidates for treatment with fluoropyrimidines
2023
·
R Tamayo Bermejo
, B Mora Rodríguez
, et al.
·
European Journal of Hospital Pharmacy
PDF
5PSQ-186 Main potential interactions detected in the outpatient consultation
2021
·
A Pintado Alvarez
, T Chinchilla Alarcon
, et al.
·
European Journal of Hospital Pharmacy
PDF
5PSQ-113 Compatibility and stability of ondansetron and midazolam mixtures used in palliative care
2020
·
M Espinosa Bosch
, F Sánchez Rojas
, et al.
·
European Journal of Hospital Pharmacy
PDF
5PSQ-120 New circuit of medication reconciliation in emergency, pharmacy and geriatrics departments
2018
·
R Tamayo Bermejo
, MA Conesa Muñoz
, et al.
·
European Journal of Hospital Pharmacy
Show more works
View as search
Works count:
31
Citation count:
960
H-index:
10
I10-index:
11
Year
Topic
Type